U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Nucleic Acid
Created
by admin
on Fri Jun 25 21:38:42 UTC 2021
Edited
by admin
on Fri Jun 25 21:38:42 UTC 2021
Nucleic Acid Type mRNA VACCINE
Nucleic Acid Subtype TRANSGENE
Sequence Origin VIRAL
Sequence Type COMPLETE
Record UNII
5TP24STD1S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZORECIMERAN
INN  
Official Name English
MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH CODON-OPTIMISED PRE-FUSION STABILIZED CONFORMATION VARIANT (K986P AND V987P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; NC_045512.2) SPIKE (S) GLYCOPROTEIN, FLANKED BY 5' AN
Common Name English
ZORECIMERAN [INN]
Common Name English
ZORECIMERAN [WHO-DD]
Common Name English
RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-AM)-CAPPED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN (986-PROLINE,987-PROLINE)-SPECIFYING 3'-TAILED MESSENGER R9515), INNER SALT
Common Name English
CV07050101
Code English
CUREVAC MRNA-BASED VACCINE IMMUNOGEN CANDIDATE AGAINST COVID-19
Common Name English
CV-07050101
Code English
CVNCOV
Code English
Code System Code Type Description
NCI_THESAURUS
C173851
Created by admin on Fri Jun 25 21:38:42 UTC 2021 , Edited by admin on Fri Jun 25 21:38:42 UTC 2021
PRIMARY NCIT
CAS
2432957-15-6
Created by admin on Fri Jun 25 21:38:42 UTC 2021 , Edited by admin on Fri Jun 25 21:38:42 UTC 2021
PRIMARY
WIKIPEDIA
CureVac_COVID-19_vaccine
Created by admin on Fri Jun 25 21:38:42 UTC 2021 , Edited by admin on Fri Jun 25 21:38:42 UTC 2021
PRIMARY
INN
11868
Created by admin on Fri Jun 25 21:38:42 UTC 2021 , Edited by admin on Fri Jun 25 21:38:42 UTC 2021
PRIMARY
FDA UNII
5TP24STD1S
Created by admin on Fri Jun 25 21:38:42 UTC 2021 , Edited by admin on Fri Jun 25 21:38:42 UTC 2021
PRIMARY
Sugar Site Range Site Count
D-Ribose (RNA) 1_1-1_4039 4039 / 4039
Linkage Site Range Site Count
Phosphate 1_1-1_4039 4039 / 4038
Related Record Type Details
TARGET ORGANISM->INHIBITOR
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
NUCLEOTIDE SUBSTITUTION [1_1] MRNA CAP M7G+M3'-5'-PPP-5'-AM2'-3'-P- VNP8CZY34V